23andMe, genetic testing
What 23andMe business troubles could mean for users' genetic data
In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced Monday that it would lay off around 40% of its workforce -- about 200 employees -- and close its drug development arm in an attempt to ...
( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...
In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback